カテゴリー： Market Monitor Global, 世界, 医療/バイオ

日本脳炎ウイルスワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Japanese Encephalitis Virus Vaccine Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8529 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：72 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Japanese Encephalitis Virus Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるの日本脳炎ウイルスワクチン市場規模と予測を収録しています。・世界の日本脳炎ウイルスワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の日本脳炎ウイルスワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の日本脳炎ウイルスワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「不活化ワクチン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

日本脳炎ウイルスワクチンのグローバル主要企業は、Research Foundation for Microbial Diseases of Osaka University、 Valneva Austria GmbH、 Chengdu Institute、 Liaoning Dacheng、 Wuhan Instituteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、日本脳炎ウイルスワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の日本脳炎ウイルスワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の日本脳炎ウイルスワクチン市場：タイプ別市場シェア、2022年
・不活化ワクチン、弱毒化生ワクチン

世界の日本脳炎ウイルスワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の日本脳炎ウイルスワクチン市場：用途別市場シェア、2022年
・公立、私立

世界の日本脳炎ウイルスワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の日本脳炎ウイルスワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における日本脳炎ウイルスワクチンのグローバル売上、2018年-2023年
・主要企業における日本脳炎ウイルスワクチンのグローバル売上シェア、2022年
・主要企業における日本脳炎ウイルスワクチンのグローバル販売量、2018年-2023年
・主要企業における日本脳炎ウイルスワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Research Foundation for Microbial Diseases of Osaka University、 Valneva Austria GmbH、 Chengdu Institute、 Liaoning Dacheng、 Wuhan Institute

*************************************************************

・調査・分析レポートの概要
日本脳炎ウイルスワクチン市場の定義
市場セグメント
世界の日本脳炎ウイルスワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の日本脳炎ウイルスワクチン市場規模
世界の日本脳炎ウイルスワクチン市場規模：2022年 VS 2029年
世界の日本脳炎ウイルスワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの日本脳炎ウイルスワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の日本脳炎ウイルスワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：不活化ワクチン、弱毒化生ワクチン
日本脳炎ウイルスワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：公立、私立
日本脳炎ウイルスワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別日本脳炎ウイルスワクチン市場規模 2022年と2029年
地域別日本脳炎ウイルスワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Research Foundation for Microbial Diseases of Osaka University、 Valneva Austria GmbH、 Chengdu Institute、 Liaoning Dacheng、 Wuhan Institute
...

Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Virus Vaccine. This report contains market size and forecasts of Japanese Encephalitis Virus Vaccine in global, including the following market information:
Global Japanese Encephalitis Virus Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Japanese Encephalitis Virus Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Japanese Encephalitis Virus Vaccine companies in 2022 (%)
The global Japanese Encephalitis Virus Vaccine market was valued at US$ 214.6 million in 2022 and is projected to reach US$ 302.4 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Inactivated Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Japanese Encephalitis Virus Vaccine include Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng and Wuhan Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Japanese Encephalitis Virus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Japanese Encephalitis Virus Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Japanese Encephalitis Virus Vaccine Market Segment Percentages, by Type, 2022 (%)
Inactivated Vaccine
Live Attenuated Vaccine
Global Japanese Encephalitis Virus Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Japanese Encephalitis Virus Vaccine Market Segment Percentages, by Application, 2022 (%)
Public
Private
Global Japanese Encephalitis Virus Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Japanese Encephalitis Virus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Japanese Encephalitis Virus Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Japanese Encephalitis Virus Vaccine revenues share in global market, 2022 (%)
Key companies Japanese Encephalitis Virus Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Japanese Encephalitis Virus Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Research Foundation for Microbial Diseases of Osaka University
Valneva Austria GmbH
Chengdu Institute
Liaoning Dacheng
Wuhan Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Japanese Encephalitis Virus Vaccine, market overview.
Chapter 2: Global Japanese Encephalitis Virus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Japanese Encephalitis Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Japanese Encephalitis Virus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Japanese Encephalitis Virus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Japanese Encephalitis Virus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Japanese Encephalitis Virus Vaccine Overall Market Size
2.1 Global Japanese Encephalitis Virus Vaccine Market Size: 2022 VS 2029
2.2 Global Japanese Encephalitis Virus Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Japanese Encephalitis Virus Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Japanese Encephalitis Virus Vaccine Players in Global Market
3.2 Top Global Japanese Encephalitis Virus Vaccine Companies Ranked by Revenue
3.3 Global Japanese Encephalitis Virus Vaccine Revenue by Companies
3.4 Global Japanese Encephalitis Virus Vaccine Sales by Companies
3.5 Global Japanese Encephalitis Virus Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Japanese Encephalitis Virus Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Japanese Encephalitis Virus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Japanese Encephalitis Virus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Japanese Encephalitis Virus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Japanese Encephalitis Virus Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Japanese Encephalitis Virus Vaccine Market Size Markets, 2022 & 2029
4.1.2 Inactivated Vaccine
4.1.3 Live Attenuated Vaccine
4.2 By Type – Global Japanese Encephalitis Virus Vaccine Revenue & Forecasts
4.2.1 By Type – Global Japanese Encephalitis Virus Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Japanese Encephalitis Virus Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Japanese Encephalitis Virus Vaccine Sales & Forecasts
4.3.1 By Type – Global Japanese Encephalitis Virus Vaccine Sales, 2018-2023
4.3.2 By Type – Global Japanese Encephalitis Virus Vaccine Sales, 2024-2029
4.3.3 By Type – Global Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Japanese Encephalitis Virus Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Japanese Encephalitis Virus Vaccine Market Size, 2022 & 2029
5.1.2 Public
5.1.3 Private
5.2 By Application – Global Japanese Encephalitis Virus Vaccine Revenue & Forecasts
5.2.1 By Application – Global Japanese Encephalitis Virus Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Japanese Encephalitis Virus Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Japanese Encephalitis Virus Vaccine Sales & Forecasts
5.3.1 By Application – Global Japanese Encephalitis Virus Vaccine Sales, 2018-2023
5.3.2 By Application – Global Japanese Encephalitis Virus Vaccine Sales, 2024-2029
5.3.3 By Application – Global Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Japanese Encephalitis Virus Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Japanese Encephalitis Virus Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Japanese Encephalitis Virus Vaccine Revenue & Forecasts
6.2.1 By Region – Global Japanese Encephalitis Virus Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Japanese Encephalitis Virus Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Japanese Encephalitis Virus Vaccine Sales & Forecasts
6.3.1 By Region – Global Japanese Encephalitis Virus Vaccine Sales, 2018-2023
6.3.2 By Region – Global Japanese Encephalitis Virus Vaccine Sales, 2024-2029
6.3.3 By Region – Global Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Japanese Encephalitis Virus Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Japanese Encephalitis Virus Vaccine Sales, 2018-2029
6.4.3 US Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.4.4 Canada Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.4.5 Mexico Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Japanese Encephalitis Virus Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Japanese Encephalitis Virus Vaccine Sales, 2018-2029
6.5.3 Germany Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.5.4 France Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.5.5 U.K. Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.5.6 Italy Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.5.7 Russia Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.5.9 Benelux Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Japanese Encephalitis Virus Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Japanese Encephalitis Virus Vaccine Sales, 2018-2029
6.6.3 China Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.6.4 Japan Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.6.5 South Korea Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.6.7 India Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Japanese Encephalitis Virus Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Japanese Encephalitis Virus Vaccine Sales, 2018-2029
6.7.3 Brazil Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.7.4 Argentina Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Japanese Encephalitis Virus Vaccine Sales, 2018-2029
6.8.3 Turkey Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.8.4 Israel Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
6.8.6 UAE Japanese Encephalitis Virus Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Research Foundation for Microbial Diseases of Osaka University
7.1.1 Research Foundation for Microbial Diseases of Osaka University Company Summary
7.1.2 Research Foundation for Microbial Diseases of Osaka University Business Overview
7.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Major Product Offerings
7.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Research Foundation for Microbial Diseases of Osaka University Key News & Latest Developments
7.2 Valneva Austria GmbH
7.2.1 Valneva Austria GmbH Company Summary
7.2.2 Valneva Austria GmbH Business Overview
7.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Major Product Offerings
7.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Valneva Austria GmbH Key News & Latest Developments
7.3 Chengdu Institute
7.3.1 Chengdu Institute Company Summary
7.3.2 Chengdu Institute Business Overview
7.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Major Product Offerings
7.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Chengdu Institute Key News & Latest Developments
7.4 Liaoning Dacheng
7.4.1 Liaoning Dacheng Company Summary
7.4.2 Liaoning Dacheng Business Overview
7.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Major Product Offerings
7.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Liaoning Dacheng Key News & Latest Developments
7.5 Wuhan Institute
7.5.1 Wuhan Institute Company Summary
7.5.2 Wuhan Institute Business Overview
7.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Major Product Offerings
7.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Wuhan Institute Key News & Latest Developments
8 Global Japanese Encephalitis Virus Vaccine Production Capacity, Analysis
8.1 Global Japanese Encephalitis Virus Vaccine Production Capacity, 2018-2029
8.2 Japanese Encephalitis Virus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Japanese Encephalitis Virus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Japanese Encephalitis Virus Vaccine Supply Chain Analysis
10.1 Japanese Encephalitis Virus Vaccine Industry Value Chain
10.2 Japanese Encephalitis Virus Vaccine Upstream Market
10.3 Japanese Encephalitis Virus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Japanese Encephalitis Virus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Japanese Encephalitis Virus Vaccine in Global Market
Table 2. Top Japanese Encephalitis Virus Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Japanese Encephalitis Virus Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Japanese Encephalitis Virus Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Japanese Encephalitis Virus Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Japanese Encephalitis Virus Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Japanese Encephalitis Virus Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Japanese Encephalitis Virus Vaccine Product Type
Table 9. List of Global Tier 1 Japanese Encephalitis Virus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Japanese Encephalitis Virus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Japanese Encephalitis Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Japanese Encephalitis Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Japanese Encephalitis Virus Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Japanese Encephalitis Virus Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Japanese Encephalitis Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Japanese Encephalitis Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Japanese Encephalitis Virus Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Japanese Encephalitis Virus Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Japanese Encephalitis Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Japanese Encephalitis Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Japanese Encephalitis Virus Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Japanese Encephalitis Virus Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Japanese Encephalitis Virus Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Japanese Encephalitis Virus Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Japanese Encephalitis Virus Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Japanese Encephalitis Virus Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Japanese Encephalitis Virus Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Japanese Encephalitis Virus Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Japanese Encephalitis Virus Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Japanese Encephalitis Virus Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Japanese Encephalitis Virus Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Japanese Encephalitis Virus Vaccine Sales, (K Units), 2024-2029
Table 46. Research Foundation for Microbial Diseases of Osaka University Company Summary
Table 47. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Offerings
Table 48. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Research Foundation for Microbial Diseases of Osaka University Key News & Latest Developments
Table 50. Valneva Austria GmbH Company Summary
Table 51. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Offerings
Table 52. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Valneva Austria GmbH Key News & Latest Developments
Table 54. Chengdu Institute Company Summary
Table 55. Chengdu Institute Japanese Encephalitis Virus Vaccine Product Offerings
Table 56. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Chengdu Institute Key News & Latest Developments
Table 58. Liaoning Dacheng Company Summary
Table 59. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Offerings
Table 60. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Liaoning Dacheng Key News & Latest Developments
Table 62. Wuhan Institute Company Summary
Table 63. Wuhan Institute Japanese Encephalitis Virus Vaccine Product Offerings
Table 64. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Wuhan Institute Key News & Latest Developments
Table 66. Japanese Encephalitis Virus Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Japanese Encephalitis Virus Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Japanese Encephalitis Virus Vaccine Production by Region, 2018-2023 (K Units)
Table 69. Global Japanese Encephalitis Virus Vaccine Production by Region, 2024-2029 (K Units)
Table 70. Japanese Encephalitis Virus Vaccine Market Opportunities & Trends in Global Market
Table 71. Japanese Encephalitis Virus Vaccine Market Drivers in Global Market
Table 72. Japanese Encephalitis Virus Vaccine Market Restraints in Global Market
Table 73. Japanese Encephalitis Virus Vaccine Raw Materials
Table 74. Japanese Encephalitis Virus Vaccine Raw Materials Suppliers in Global Market
Table 75. Typical Japanese Encephalitis Virus Vaccine Downstream
Table 76. Japanese Encephalitis Virus Vaccine Downstream Clients in Global Market
Table 77. Japanese Encephalitis Virus Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Japanese Encephalitis Virus Vaccine Segment by Type in 2022
Figure 2. Japanese Encephalitis Virus Vaccine Segment by Application in 2022
Figure 3. Global Japanese Encephalitis Virus Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Japanese Encephalitis Virus Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Japanese Encephalitis Virus Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Japanese Encephalitis Virus Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Japanese Encephalitis Virus Vaccine Revenue in 2022
Figure 9. By Type - Global Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Japanese Encephalitis Virus Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Japanese Encephalitis Virus Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 23. US Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 37. China Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Japanese Encephalitis Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Japanese Encephalitis Virus Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Japanese Encephalitis Virus Vaccine by Region, 2022 VS 2029
Figure 54. Japanese Encephalitis Virus Vaccine Industry Value Chain
Figure 55. Marketing Channels

※参考情報

日本脳炎ウイルスワクチンは、日本脳炎というウイルス性の感染症を予防するためのワクチンです。この病気は主に蚊を媒介として人に感染し、重篤な神経系の合併症を引き起こすことがあります。特に発展途上国や、特定の地域において高いリスクがあるため、ワクチン接種が重要とされています。

日本脳炎ウイルスは、フラビウイルス科に属し、主に豚や鳥に生息しますが、これらの動物が蚊にとって主な宿主になります。感染は、特に農村地域で広がりやすく、蚊が人を刺すことでウイルスが移行し、最終的に人間に感染をもたらす仕組みです。感染が進行すると、発熱、頭痛、痙攣、意識障害などの臨床症状が現れ、重症化すると脳炎を引き起こすこともあります。

日本脳炎ウイルスワクチンの主な特徴は、効果的な予防を提供し、感染のリスクを大幅に低下させることです。多くの国々では、特に高リスク地域に居住している人々や旅行者に対してワクチン接種が推奨されています。また、ワクチンは通常、数回の接種によって強化され、持続的な免疫を形成します。

現在、主に使用されている日本脳炎ウイルスワクチンは、いくつかの種類があります。その中でも、従来型の不活化ワクチンと、遺伝子組換えワクチンがあります。不活化ワクチンは、ウイルスを化学的に不活化したものを使用しており、安全性が高いですが、通常は数回の接種が必要です。一方で、遺伝子組換えワクチンは、特定のウイルスの一部を利用して免疫応答を促すため、製造が迅速かつ効率的であり、少ない回数の接種で効果が得られることが多いです。

日本脳炎ウイルスワクチンの用途は、主に公衆衛生の観点から、感染症の発生を防ぐことです。特に日本脳炎が流行する地域において、住民や旅行者にワクチン接種を行うことで、集団免疫が形成され、ウイルスが拡散するリスクが低下します。また、発展途上国では、このワクチンが特に重要であり、農業従事者やその家族が感染する危険性が高いため、適切なタイミングでの接種が求められています。

関連技術の面では、ワクチンの開発には先進的な生物技術が利用されています。たとえば、遺伝子組換え技術を用いることで、低コストで効率的にワクチンを製造することが可能になり、ワクチン供給の安定性が向上しています。また、疫学的なデータとGIS（地理情報システム）を活用して、感染リスクの高い地域を特定する取り組みも進められていますこれにより、効果的なワクチン接種キャンペーンを計画し、実施することができるようになりました。

さらに、今後の疫病対策として、高性能な診断技術の開発も重要です。日本脳炎ウイルスに感染しているかどうかを迅速に判断できる検査があれば、感染者の早期発見および治療が進められ、さらなる感染拡大を抑制できるでしょう。また、ワクチンの効果を長持ちさせるための研究や、新たな免疫応答を誘導するアプローチも注目されています。

日本脳炎ウイルスワクチンの接種によって、個人の健康を守るだけでなく、地域全体の公衆衛生を向上させることが可能です。特に、地域社会でのアウトブレイクを防ぐためには、適切なワクチン接種が重要であり、周知や教育が intensa に行われるべきです。これには、医療従事者のトレーニングや、一般の人々への情報提供が含まれます。

結論として、日本脳炎ウイルスワクチンは、重篤な神経疾患を予防するための重要なツールであり、その効果的な使用によって、感染症の流行を大幅に抑えることができます。今後も、ワクチンの改良に向けた研究と、より効果的な公衆衛生戦略の展開が求められます。 სეზ[['

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 日本脳炎ウイルスワクチンの世界市場見通し2023年-2029年(Japanese Encephalitis Virus Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

日本脳炎ウイルスワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp